sunpharm
corp
said
thursday
closed
private
placement
1.83
million
units
gross
proceeds
approximately
6.4
million
unit
consists
share
sunpharm
common
stock
warrant
purchase
additional
share.the
proceeds
private
placement
provide
sunpharm
funding
years
operations
said
sunpharm.the
company
added
use
money
accelerate
product
organizational
development
programs
human
clinical
trial
programs
underway
proprietary
polyamine
analogue
based
products.the
company
said
named
charles
dimmler
hambro
health
international
new
seat
board
directors
